{"id": "153881", "url": "https://fevir.net/resources/Citation/153881", "meta": {"versionId": "11", "lastUpdated": "2025-10-12T18:47:15.699Z"}, "title": "Delany-Moretlwe 2022 clinical trial", "author": [{"name": "Brian S. Alper"}, {"name": "Computable Publishing\u00ae: MEDLINE-to-FEvIR Converter"}], "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "summary": [{"text": "Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial [Journal Article]. Contributors: Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, Kayange N, Makhema J, Mandima P, Mathew C, Spooner E, Mpendo J, Mukwekwerere P, Mgodi N, Ntege PN, Nair G, Nakabiito C, Nuwagaba-Biribonwoha H, Panchia R, Singh N, Siziba B, Farrior J, Rose S, Anderson PL, Eshleman SH, Marzinke MA, Hendrix CW, Beigel-Orme S, Hosek S, Tolley E, Sista N, Adeyeye A, Rooney JF, Rinehart A, Spreen WR, Smith K, Hanscom B, Cohen MS, Hosseinipour MC, HPTN 084 study group. In: Lancet (London, England), PMID 35378077. Published May 07, 2022. Available at: https://pubmed.ncbi.nlm.nih.gov/35378077/.", "style": {"coding": [{"code": "comppub", "system": "http://hl7.org/fhir/citation-summary-style", "display": "Computable Publishing"}]}}], "contained": [{"id": "meshHeading0", "content": [{"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D000328", "system": "https://www.nlm.nih.gov/mesh", "display": "Adult", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D005260", "system": "https://www.nlm.nih.gov/mesh", "display": "Female", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D006801", "system": "https://www.nlm.nih.gov/mesh", "display": "Humans", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D011247", "system": "https://www.nlm.nih.gov/mesh", "display": "Pregnancy", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is Major topic"}]}], "classifier": [{"coding": [{"code": "D019380", "system": "https://www.nlm.nih.gov/mesh", "display": "Anti-HIV Agents", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D054659", "system": "https://www.nlm.nih.gov/mesh", "display": "Diketopiperazines", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000627", "system": "https://www.nlm.nih.gov/mesh", "display": "therapeutic use"}]}]}], "classifier": [{"coding": [{"code": "D000068679", "system": "https://www.nlm.nih.gov/mesh", "display": "Emtricitabine", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is Major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000139", "system": "https://www.nlm.nih.gov/mesh", "display": "chemically induced"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000453", "system": "https://www.nlm.nih.gov/mesh", "display": "epidemiology"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000517", "system": "https://www.nlm.nih.gov/mesh", "display": "prevention & control"}]}]}], "classifier": [{"coding": [{"code": "D015658", "system": "https://www.nlm.nih.gov/mesh", "display": "HIV Infections", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is Major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000188", "system": "https://www.nlm.nih.gov/mesh", "display": "drug therapy"}]}]}], "classifier": [{"coding": [{"code": "D006679", "system": "https://www.nlm.nih.gov/mesh", "display": "HIV Seropositivity", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is Major topic"}]}], "classifier": [{"coding": [{"code": "D015497", "system": "https://www.nlm.nih.gov/mesh", "display": "HIV-1", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000627", "system": "https://www.nlm.nih.gov/mesh", "display": "therapeutic use"}]}]}], "classifier": [{"coding": [{"code": "D011728", "system": "https://www.nlm.nih.gov/mesh", "display": "Pyridones", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D008297", "system": "https://www.nlm.nih.gov/mesh", "display": "Male", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D000293", "system": "https://www.nlm.nih.gov/mesh", "display": "Adolescent", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D055815", "system": "https://www.nlm.nih.gov/mesh", "display": "Young Adult", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D008875", "system": "https://www.nlm.nih.gov/mesh", "display": "Middle Aged", "userSelected": false}]}], "freeToShare": true}], "resourceType": "ArtifactAssessment", "artifactReference": {"type": "Citation", "reference": "#"}}, {"id": "contributor0", "name": [{"given": ["Sinead"], "family": "Delany-Moretlwe"}], "resourceType": "Practitioner"}, {"id": "contributor1", "name": [{"given": ["James P"], "family": "Hughes"}], "resourceType": "Practitioner"}, {"id": "contributor2", "name": [{"given": ["Peter"], "family": "Bock"}], "resourceType": "Practitioner"}, {"id": "contributor3", "name": [{"given": ["Samuel Gurrion"], "family": "Ouma"}], "resourceType": "Practitioner"}, {"id": "contributor4", "name": [{"given": ["Portia"], "family": "Hunidzarira"}], "resourceType": "Practitioner"}, {"id": "contributor5", "name": [{"given": ["Dishiki"], "family": "Kalonji"}], "resourceType": "Practitioner"}, {"id": "contributor6", "name": [{"given": ["Noel"], "family": "Kayange"}], "resourceType": "Practitioner"}, {"id": "contributor7", "name": [{"given": ["Joseph"], "family": "Makhema"}], "resourceType": "Practitioner"}, {"id": "contributor8", "name": [{"given": ["Patricia"], "family": "Mandima"}], "resourceType": "Practitioner"}, {"id": "contributor9", "name": [{"given": ["Carrie"], "family": "Mathew"}], "resourceType": "Practitioner"}, {"id": "contributor10", "name": [{"given": ["Elizabeth"], "family": "Spooner"}], "resourceType": "Practitioner"}, {"id": "contributor11", "name": [{"given": ["Juliet"], "family": "Mpendo"}], "resourceType": "Practitioner"}, {"id": "contributor12", "name": [{"given": ["Pamela"], "family": "Mukwekwerere"}], "resourceType": "Practitioner"}, {"id": "contributor13", "name": [{"given": ["Nyaradzo"], "family": "Mgodi"}], "resourceType": "Practitioner"}, {"id": "contributor14", "name": [{"given": ["Patricia Nahirya"], "family": "Ntege"}], "resourceType": "Practitioner"}, {"id": "contributor15", "name": [{"given": ["Gonasagrie"], "family": "Nair"}], "resourceType": "Practitioner"}, {"id": "contributor16", "name": [{"given": ["Clemensia"], "family": "Nakabiito"}], "resourceType": "Practitioner"}, {"id": "contributor17", "name": [{"given": ["Harriet"], "family": "Nuwagaba-Biribonwoha"}], "resourceType": "Practitioner"}, {"id": "contributor18", "name": [{"given": ["Ravindre"], "family": "Panchia"}], "resourceType": "Practitioner"}, {"id": "contributor19", "name": [{"given": ["Nishanta"], "family": "Singh"}], "resourceType": "Practitioner"}, {"id": "contributor20", "name": [{"given": ["Bekezela"], "family": "Siziba"}], "resourceType": "Practitioner"}, {"id": "contributor21", "name": [{"given": ["Jennifer"], "family": "Farrior"}], "resourceType": "Practitioner"}, {"id": "contributor22", "name": [{"given": ["Scott"], "family": "Rose"}], "resourceType": "Practitioner"}, {"id": "contributor23", "name": [{"given": ["Peter L"], "family": "Anderson"}], "resourceType": "Practitioner"}, {"id": "contributor24", "name": [{"given": ["Susan H"], "family": "Eshleman"}], "resourceType": "Practitioner"}, {"id": "contributor25", "name": [{"given": ["Mark A"], "family": "Marzinke"}], "resourceType": "Practitioner"}, {"id": "contributor26", "name": [{"given": ["Craig W"], "family": "Hendrix"}], "resourceType": "Practitioner"}, {"id": "contributor27", "name": [{"given": ["Stephanie"], "family": "Beigel-Orme"}], "resourceType": "Practitioner"}, {"id": "contributor28", "name": [{"given": ["Sybil"], "family": "Hosek"}], "resourceType": "Practitioner"}, {"id": "contributor29", "name": [{"given": ["Elizabeth"], "family": "Tolley"}], "resourceType": "Practitioner"}, {"id": "contributor30", "name": [{"given": ["Nirupama"], "family": "Sista"}], "resourceType": "Practitioner"}, {"id": "contributor31", "name": [{"given": ["Adeola"], "family": "Adeyeye"}], "resourceType": "Practitioner"}, {"id": "contributor32", "name": [{"given": ["James F"], "family": "Rooney"}], "resourceType": "Practitioner"}, {"id": "contributor33", "name": [{"given": ["Alex"], "family": "Rinehart"}], "resourceType": "Practitioner"}, {"id": "contributor34", "name": [{"given": ["William R"], "family": "Spreen"}], "resourceType": "Practitioner"}, {"id": "contributor35", "name": [{"given": ["Kimberly"], "family": "Smith"}], "resourceType": "Practitioner"}, {"id": "contributor36", "name": [{"given": ["Brett"], "family": "Hanscom"}], "resourceType": "Practitioner"}, {"id": "contributor37", "name": [{"given": ["Myron S"], "family": "Cohen"}], "resourceType": "Practitioner"}, {"id": "contributor38", "name": [{"given": ["Mina C"], "family": "Hosseinipour"}], "resourceType": "Practitioner"}, {"id": "contributor39", "name": "HPTN 084 study group", "resourceType": "Organization"}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "153881", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"value": "35378077", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}], "statusDate": [{"period": {"end": "2022-02-27"}, "activity": {"coding": [{"code": "pubmed-pubstatus-received", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Received"}]}}, {"period": {"end": "2022-03-12"}, "activity": {"coding": [{"code": "pubmed-pubstatus-revised", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Revised"}]}}, {"period": {"end": "2022-03-14"}, "activity": {"coding": [{"code": "pubmed-pubstatus-accepted", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Accepted"}]}}, {"period": {"end": "2022-04-05T06:00:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-pubmed", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of PubMed"}]}}, {"period": {"end": "2022-05-11T06:00:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-medline", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Medline"}]}}, {"period": {"end": "2022-04-04T20:10:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-entrez", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Entrez"}]}}], "useContext": [{"code": {"code": "fevir-platform-use", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "FEvIR Platform Use"}, "valueCodeableConcept": {"coding": [{"code": "project-specific", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Project Specific"}]}}], "approvalDate": "2022-05-10", "currentState": [{"coding": [{"code": "medline-medline", "system": "http://hl7.org/fhir/citation-status-type", "display": "Medline Citation Status of MEDLINE"}]}, {"coding": [{"code": "pubmed-publication-status-ppublish", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed PublicationStatus of ppublish"}]}], "resourceType": "Citation", "citedArtifact": {"title": [{"text": "Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.", "type": [{"coding": [{"code": "primary", "system": "http://terminology.hl7.org/CodeSystem/title-type", "display": "Primary title"}]}], "language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}}], "abstract": [{"text": "**BACKGROUND:** Oral pre-exposure prophylaxis has been introduced in more than 70 countries, including many in sub-Saharan Africa, but women experience considerable barriers to daily pill-taking, such as stigma, judgement, and the fear of violence. Safe and effective long-acting agents for HIV prevention are needed for women. We aimed to evaluate the safety and efficacy of injectable cabotegravir compared with daily oral tenofovir diphosphate plus emtricitabine (TDF-FTC) for HIV prevention in HIV-uninfected women.\n**METHODS:** HPTN 084 was a phase 3, randomised, double-blind, double-dummy, active-controlled, superiority trial in 20 clinical research sites in seven countries in sub-Saharan Africa. Participants were eligible for enrolment if they were assigned female sex at birth, were aged 18-45 years, reported at least two episodes of vaginal intercourse in the previous 30 days, were at risk of HIV infection based on an HIV risk score, and agreed to use a long-acting reversible contraceptive method. Participants were randomly assigned (1:1) to either active cabotegravir with TDF-FTC placebo (cabotegravir group) or active TDF-FTC with cabotegravir placebo (TDF-FTC group). Study staff and participants were masked to study group allocation, with the exception of the site pharmacist who was responsible for study product preparation. Participants were prescribed 5 weeks of daily oral product followed by intramuscular injections every 8 weeks after an initial 4-week interval load, alongside daily oral pills. Participants who discontinued injections were offered open-label daily TDF-FTC for 48 weeks. The primary endpoints of the study were incident HIV infection in the intention-to-treat population, and clinical and laboratory events that were grade 2 or higher in all women who had received at least one dose of study product. This study is registered with ClinicalTrials.gov, NCT03164564.\n**FINDINGS:** From Nov 27, 2017, to Nov 4, 2020, we enrolled 3224 participants (1614 in the cabotegravir group and 1610 in the TDF-FTC group). Median age was 25 years (IQR 22-30); 1755 (54\u00b77%) of 3209 had two or more partners in the preceding month. 40 incident infections were observed over 3898 person-years (HIV incidence 1\u00b70% [95% CI 0\u00b773-1\u00b740]); four in the cabotegravir group (HIV incidence 0\u00b72 cases per 100 person-years [0\u00b706-0\u00b752]) and 36 in the TDF-FTC group (1\u00b785 cases per 100 person-years [1\u00b73-2\u00b757]; hazard ratio 0\u00b712 [0\u00b705-0\u00b731]; p&lt;0\u00b70001; risk difference -1\u00b76% [-1\u00b70% to -2\u00b73%]. In a random subset of 405 TDF-FTC participants, 812 (42\u00b71%) of 1929 plasma samples had tenofovir concentrations consistent with daily use. Injection coverage was 93% of the total number of person-years. Adverse event rates were similar across both groups, apart from injection site reactions, which were more frequent in the cabotegravir group than in the TDF-FTC group (577 [38\u00b70%] of 1519 vs 162 [10\u00b77%] of 1516]) but did not result in injection discontinuation. Confirmed pregnancy incidence was 1\u00b73 per 100 person-years (0\u00b79-1\u00b77); no congenital birth anomalies were reported.\n**INTERPRETATION:** Although both products for HIV prevention were generally safe, well tolerated, and effective, cabotegravir was superior to TDF-FTC in preventing HIV infection in women.\n**FUNDING:** National Institute of Allergy and Infectious Diseases, ViiV Healthcare, and the Bill &amp; Melinda Gates Foundation. Additional support was provided through the National Institute of Mental Health, the National Institute on Drug Abuse, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. ViiV Healthcare and Gilead Sciences provided pharmaceutical support.", "copyright": "Copyright \u00a9 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved."}], "relatesTo": [{"type": "cites", "citation": "UNAIDS  Confronting inequalities: lessons for pandemic responses from 40 years of AIDS. July 14, 2021. https://www.unaids.org/en/resources/documents/2021/2021-global-aids-update-slideset"}, {"type": "cites", "citation": "WHO . World Health Organization; Geneva: 2015. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP)"}, {"type": "cites", "citation": "Celum CL, Delany-Moretlwe S, Baeten JM, et al. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22(suppl 4)", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/31328444/", "identifier": {"value": "31328444", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Velloza J, Khoza N, Scorgie F, et al. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study. J Int AIDS Soc. 2020;23", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "32144874", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/32144874/"}}, {"type": "cites", "citation": "Cottrell ML, Yang KH, Prince HM, et al. A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine. J Infect Dis. 2016;214:55\u201364.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "26917574", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26917574/"}}, {"type": "cites", "citation": "Andrews CD, Yueh YL, Spreen WR, et al. A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge. Sci Transl Med. 2015;7", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "25589630", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/25589630/"}}, {"type": "cites", "citation": "Radzio J, Spreen W, Yueh YL, et al. The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge. Sci Transl Med. 2015;7", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "25589631", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/25589631/"}}, {"type": "cites", "citation": "Markowitz M, Frank I, Grant RM, et al. Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial. Lancet HIV. 2017;4:e331\u2013e340.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "28546090", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/28546090/"}}, {"type": "cites", "citation": "Landovitz RJ, Li S, Grinsztejn B, et al. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018;15", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "30408115", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/30408115/"}}, {"type": "cites", "citation": "Landovitz RJ, Donnell D, Clement ME, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385:595\u2013608.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "34379922", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/34379922/"}}, {"type": "cites", "citation": "Balkus JE, Brown E, Palanee T, et al. An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2016;72:333\u2013343.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "26918545", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26918545/"}}, {"type": "cites", "citation": "Eshleman SH, Fogel JM, Piwowar-Manning E, et al. Characterization of HIV infections in women who received injectable cabotegravir or tenofovir disoproxil fumarate/emtricitabine for HIV prevention: HPTN 084. J Infect Dis (in press).", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "35301540", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/35301540/"}}, {"type": "cites", "citation": "Castillo-Mancilla JR, Zheng JH, Rower JE, et al. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure. AIDS Res Hum Retroviruses. 2013;29:384\u2013390.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "22935078", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/22935078/"}}, {"type": "cites", "citation": "Anderson PL, Liu AY, Castillo-Mancilla JR, et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrob Agents Chemother. 2017;62:e01710\u2013e01717.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "29038282", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/29038282/"}}, {"type": "cites", "citation": "Hendrix CW, Andrade A, Bumpus NN, et al. Dose frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed dosing in healthy volunteers to establish adherence benchmarks (HPTN 066) AIDS Res Hum Retroviruses. 2016;32:32\u201343.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "26414912", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/26414912/"}}, {"type": "cites", "citation": "Donnell D, Baeten JM, Bumpus NN, et al. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014;66:340\u2013348.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "24784763", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/24784763/"}}, {"type": "cites", "citation": "Marzinke MA, Grinsztejn B, Fogel JM, et al. Characterization of human immunodeficiency virus (HIV) infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083. J Infect Dis. 2021;224:1581\u20131592.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "33740057", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/33740057/"}}, {"type": "cites", "citation": "US Department of Health and Human Services  Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, corrected version 2.1. July, 2017. https://rsc.niaid.nih.gov/sites/default/files/daidsgradingcorrectedv21.pdf"}, {"type": "cites", "citation": "Emerson SS, Fleming TR. Parameter estimation following group sequential hypothesis testing. Biometrika. 1990;77:875\u2013892."}, {"type": "cites", "citation": "Corey L, Gilbert PB, Juraska M, et al. Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition. N Engl J Med. 2021;384:1003\u20131014.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "33730454", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/33730454/"}}, {"type": "cites", "citation": "Gray GE, Bekker LG, Laher F, et al. Vaccine efficacy of ALVAC-HIV and bivalent subtype C gp120-MF59 in adults. N Engl J Med. 2021;384:1089\u20131100.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "33761206", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/33761206/"}}, {"type": "cites", "citation": "Palanee-Phillips T, Baeten J, Heller K, et al. HIV incidence remains high in women in South Africa: data from the ECHO trial. 10th International AIDS Society Conference on HIV Science; July 21\u201324, 2019 (abstr LBPEC23)."}, {"type": "cites", "citation": "Pillay D, Stankevitz K, Lanham M, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS One. 2020;15", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "32352969", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/32352969/"}}, {"type": "cites", "citation": "B\u00e4rnighausen K, Geldsetzer P, Matse S, et al. Qualitative accounts of PrEP discontinuation from the general population in Eswatini. Cult Health Sex. 2021;23:1198\u20131214.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "32633617", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/32633617/"}}, {"type": "cites", "citation": "Quaife M, Eakle R, Cabrera Escobar MA, et al. Divergent preferences for HIV prevention: a discrete choice experiment for multipurpose HIV prevention products in South Africa. Med Decis Making. 2018;38:120\u2013133.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "28863752", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/28863752/"}}, {"type": "cites", "citation": "Minnis AM, Browne EN, Boeri M, et al. Young women's stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019;80:394\u2013403.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "30633040", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/30633040/"}}, {"type": "cites", "citation": "Laher F, Salami T, Hornschuh S, et al. Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important. BMC Public Health. 2020;20", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "33160341", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/33160341/"}}, {"type": "cites", "citation": "Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372:509\u2013518.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "25651245", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/25651245/"}}, {"type": "cites", "citation": "Baeten JM, Brown ER, Hillier SL. Dapivirine vaginal ring for HIV-1 prevention. N Engl J Med. 2017;376:995\u2013996.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "28273023", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/28273023/"}}, {"type": "cites", "citation": "Venter WDF, Moorhouse M, Sokhela S, et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381:803\u2013815.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "31339677", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/31339677/"}}, {"type": "cites", "citation": "Landovitz RJ, Zangeneh SZ, Chau G, et al. Cabotegravir is not associated with weight gain in human immunodeficiency virus-uninfected individuals in HPTN 077. Clin Infect Dis. 2020;70:319\u2013322.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"identifier": {"value": "31125395", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/31125395/"}}, {"type": "cites", "citation": "Eshleman S, Fogel JM, Halvas EK, et al. CAB-LA PrEP: early detection of HIV infection may reduce InSTI resistance risk. 29th Conference on Retroviruses and Opportunistic Infections; Feb 12\u201316, 2022 (abstr Oral-08)."}, {"type": "comment-in", "citation": "Lancet. 2022 May 7;399(10337):1754-1755", "classifier": [{"coding": [{"code": "D016420", "system": "https://www.nlm.nih.gov/mesh", "display": "Comment", "userSelected": false}]}], "targetReference": {"identifier": {"value": "35378079", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/35378079/"}}, {"type": "correction-in", "citation": "Lancet. 2022 May 7;399(10337):1778", "classifier": [{"coding": [{"code": "D016425", "system": "https://www.nlm.nih.gov/mesh", "display": "Published Erratum", "userSelected": false}]}], "targetReference": {"identifier": {"value": "35526551", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/35526551/"}}, {"type": "comment-in", "citation": "Nat Med. 2022 Aug;28(8):1542-1543", "classifier": [{"coding": [{"code": "D016420", "system": "https://www.nlm.nih.gov/mesh", "display": "Comment", "userSelected": false}]}], "targetReference": {"identifier": {"value": "35869309", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/35869309/"}}, {"type": "comment-in", "citation": "Nature. 2022 Aug;608(7923):460-461", "classifier": [{"coding": [{"code": "D016420", "system": "https://www.nlm.nih.gov/mesh", "display": "Comment", "userSelected": false}]}], "targetReference": {"identifier": {"value": "35931763", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/35931763/"}}, {"type": "comment-in", "citation": "Nature. 2022 Aug;608(7922):239", "classifier": [{"coding": [{"code": "D016420", "system": "https://www.nlm.nih.gov/mesh", "display": "Comment", "userSelected": false}]}], "targetReference": {"identifier": {"value": "35945377", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, "reference": "https://pubmed.ncbi.nlm.nih.gov/35945377/"}}], "identifier": [{"value": "35378077", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}, {"value": "PMC9077443", "system": "https://www.ncbi.nlm.nih.gov/pmc/", "assigner": {"display": "NLM"}}, {"value": "10.1016/S0140-6736(22)00538-4", "system": "https://doi.org"}, {"type": {"text": "pii", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "S0140-6736(22)00538-4"}], "webLocation": [{"url": "https://pubmed.ncbi.nlm.nih.gov/35378077/", "classifier": [{"coding": [{"code": "abstract", "system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "display": "Abstract"}]}]}, {"url": "https://doi.org/10.1016/S0140-6736(22)00538-4", "classifier": [{"coding": [{"code": "doi-based", "system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "display": "DOI Based"}]}]}], "classification": [{"type": {"coding": [{"code": "publishing-model", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Publishing Model", "userSelected": false}]}, "classifier": [{"coding": [{"code": "Print-Electronic", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Print Electronic", "userSelected": false}]}]}, {"type": {"coding": [{"code": "chemical", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Chemical", "userSelected": false}]}, "classifier": [{"coding": [{"code": "D019380", "system": "https://www.nlm.nih.gov/mesh", "display": "Anti-HIV Agents", "userSelected": false}]}, {"coding": [{"code": "D054659", "system": "https://www.nlm.nih.gov/mesh", "display": "Diketopiperazines", "userSelected": false}]}, {"coding": [{"code": "D011728", "system": "https://www.nlm.nih.gov/mesh", "display": "Pyridones", "userSelected": false}]}, {"coding": [{"code": "G70B4ETF4S", "system": "https://www.cas.org/support/documentation/chemical-substances", "userSelected": false}, {"code": "D000068679", "system": "https://www.nlm.nih.gov/mesh", "display": "Emtricitabine", "userSelected": false}]}, {"coding": [{"code": "HMH0132Z1Q", "system": "https://www.cas.org/support/documentation/chemical-substances", "userSelected": false}, {"code": "C584914", "system": "https://www.nlm.nih.gov/mesh", "display": "cabotegravir", "userSelected": false}]}]}, {"type": {"coding": [{"code": "publication-type", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Publication type"}]}, "classifier": [{"coding": [{"code": "D017428", "system": "https://www.nlm.nih.gov/mesh", "display": "Clinical Trial, Phase III", "userSelected": false}]}, {"coding": [{"code": "D016428", "system": "https://www.nlm.nih.gov/mesh", "display": "Journal Article", "userSelected": false}]}, {"coding": [{"code": "D016449", "system": "https://www.nlm.nih.gov/mesh", "display": "Randomized Controlled Trial", "userSelected": false}]}]}, {"type": {"coding": [{"code": "citation-subset", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Citation subset", "userSelected": false}]}, "classifier": [{"coding": [{"code": "IM", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset", "display": "IM", "userSelected": false}]}]}, {"type": {"coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH Heading"}]}, "artifactAssessment": [{"type": "ArtifactAssessment", "reference": "#meshHeading0"}]}, {"type": {"coding": [{"code": "knowledge-artifact-type", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Knowledge Artifact Type", "userSelected": false}]}, "classifier": [{"coding": [{"code": "D016428", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Journal Article", "userSelected": false}]}], "artifactAssessment": [{"display": "Classifier added by Computable Publishing LLC"}]}], "contributorship": {"entry": [{"affiliation": [{"display": "Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: sdelany@wrhi.ac.za."}], "contributor": {"type": "Practitioner", "display": "Delany-Moretlwe S", "reference": "#contributor0"}, "forenameInitials": "S"}, {"affiliation": [{"display": "Statistical Centre for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA."}], "contributor": {"type": "Practitioner", "display": "Hughes JP", "reference": "#contributor1"}, "forenameInitials": "JP"}, {"affiliation": [{"display": "Desmond Tutu TB Centre, University of Stellenbosch, Stellenbosch, South Africa."}], "contributor": {"type": "Practitioner", "display": "Bock P", "reference": "#contributor2"}, "forenameInitials": "P"}, {"affiliation": [{"display": "Kisumu Clinical Research Site, Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya."}], "contributor": {"type": "Practitioner", "display": "Ouma SG", "reference": "#contributor3"}, "forenameInitials": "SG"}, {"affiliation": [{"display": "Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe."}], "contributor": {"type": "Practitioner", "display": "Hunidzarira P", "reference": "#contributor4"}, "forenameInitials": "P"}, {"affiliation": [{"display": "HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa."}], "contributor": {"type": "Practitioner", "display": "Kalonji D", "reference": "#contributor5"}, "forenameInitials": "D"}, {"affiliation": [{"display": "Blantyre Clinical Research Site, College of Medicine, University of Malawi, Blantyre, Malawi."}], "contributor": {"type": "Practitioner", "display": "Kayange N", "reference": "#contributor6"}, "forenameInitials": "N"}, {"affiliation": [{"display": "Botswana Harvard AIDS Institute Partnership (BHP), Gaborone, Botswana."}], "contributor": {"type": "Practitioner", "display": "Makhema J", "reference": "#contributor7"}, "forenameInitials": "J"}, {"affiliation": [{"display": "Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe."}], "contributor": {"type": "Practitioner", "display": "Mandima P", "reference": "#contributor8"}, "forenameInitials": "P"}, {"affiliation": [{"display": "Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa."}], "contributor": {"type": "Practitioner", "display": "Mathew C", "reference": "#contributor9"}, "forenameInitials": "C"}, {"affiliation": [{"display": "HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa."}], "contributor": {"type": "Practitioner", "display": "Spooner E", "reference": "#contributor10"}, "forenameInitials": "E"}, {"affiliation": [{"display": "International AIDS Vaccine Initiative, Uganda Virus Research Institute, Entebbe, Uganda."}], "contributor": {"type": "Practitioner", "display": "Mpendo J", "reference": "#contributor11"}, "forenameInitials": "J"}, {"affiliation": [{"display": "Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe."}], "contributor": {"type": "Practitioner", "display": "Mukwekwerere P", "reference": "#contributor12"}, "forenameInitials": "P"}, {"affiliation": [{"display": "Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe."}], "contributor": {"type": "Practitioner", "display": "Mgodi N", "reference": "#contributor13"}, "forenameInitials": "N"}, {"affiliation": [{"display": "Baylor College of Medicine Children's Foundation Uganda, Kampala, Uganda."}], "contributor": {"type": "Practitioner", "display": "Ntege PN", "reference": "#contributor14"}, "forenameInitials": "PN"}, {"affiliation": [{"display": "Desmond Tutu Health Foundation, University of Cape Town, Cape Town, South Africa."}], "contributor": {"type": "Practitioner", "display": "Nair G", "reference": "#contributor15"}, "forenameInitials": "G"}, {"affiliation": [{"display": "Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda."}], "contributor": {"type": "Practitioner", "display": "Nakabiito C", "reference": "#contributor16"}, "forenameInitials": "C"}, {"affiliation": [{"display": "Eswatini Prevention Center, International Center for AIDS Care and Treatment Program at Columbia University Mailman School of Public Health, New York, NY, USA."}], "contributor": {"type": "Practitioner", "display": "Nuwagaba-Biribonwoha H", "reference": "#contributor17"}, "forenameInitials": "H"}, {"affiliation": [{"display": "Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa."}], "contributor": {"type": "Practitioner", "display": "Panchia R", "reference": "#contributor18"}, "forenameInitials": "R"}, {"affiliation": [{"display": "HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa."}], "contributor": {"type": "Practitioner", "display": "Singh N", "reference": "#contributor19"}, "forenameInitials": "N"}, {"affiliation": [{"display": "Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe."}], "contributor": {"type": "Practitioner", "display": "Siziba B", "reference": "#contributor20"}, "forenameInitials": "B"}, {"affiliation": [{"display": "FHI 360, Durham, NC, USA."}], "contributor": {"type": "Practitioner", "display": "Farrior J", "reference": "#contributor21"}, "forenameInitials": "J"}, {"affiliation": [{"display": "FHI 360, Durham, NC, USA."}], "contributor": {"type": "Practitioner", "display": "Rose S", "reference": "#contributor22"}, "forenameInitials": "S"}, {"affiliation": [{"display": "Anschutz Medical Campus, University of Colorado, Aurora, CO, USA."}], "contributor": {"type": "Practitioner", "display": "Anderson PL", "reference": "#contributor23"}, "forenameInitials": "PL"}, {"affiliation": [{"display": "Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA."}], "contributor": {"type": "Practitioner", "display": "Eshleman SH", "reference": "#contributor24"}, "forenameInitials": "SH"}, {"affiliation": [{"display": "Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."}], "contributor": {"type": "Practitioner", "display": "Marzinke MA", "reference": "#contributor25"}, "forenameInitials": "MA"}, {"affiliation": [{"display": "Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."}], "contributor": {"type": "Practitioner", "display": "Hendrix CW", "reference": "#contributor26"}, "forenameInitials": "CW"}, {"affiliation": [{"display": "Statistical Centre for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA."}], "contributor": {"type": "Practitioner", "display": "Beigel-Orme S", "reference": "#contributor27"}, "forenameInitials": "S"}, {"affiliation": [{"display": "Department of Psychiatry, Stroger Hospital of Cook County, Chicago, IL, USA."}], "contributor": {"type": "Practitioner", "display": "Hosek S", "reference": "#contributor28"}, "forenameInitials": "S"}, {"affiliation": [{"display": "FHI 360, Durham, NC, USA."}], "contributor": {"type": "Practitioner", "display": "Tolley E", "reference": "#contributor29"}, "forenameInitials": "E"}, {"affiliation": [{"display": "FHI 360, Durham, NC, USA."}], "contributor": {"type": "Practitioner", "display": "Sista N", "reference": "#contributor30"}, "forenameInitials": "N"}, {"affiliation": [{"display": "Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, MD, USA."}], "contributor": {"type": "Practitioner", "display": "Adeyeye A", "reference": "#contributor31"}, "forenameInitials": "A"}, {"affiliation": [{"display": "Gilead Sciences, Foster City, CA, USA."}], "contributor": {"type": "Practitioner", "display": "Rooney JF", "reference": "#contributor32"}, "forenameInitials": "JF"}, {"affiliation": [{"display": "ViiV Healthcare, Durham, NC, USA."}], "contributor": {"type": "Practitioner", "display": "Rinehart A", "reference": "#contributor33"}, "forenameInitials": "A"}, {"affiliation": [{"display": "ViiV Healthcare, Durham, NC, USA."}], "contributor": {"type": "Practitioner", "display": "Spreen WR", "reference": "#contributor34"}, "forenameInitials": "WR"}, {"affiliation": [{"display": "ViiV Healthcare, Durham, NC, USA."}], "contributor": {"type": "Practitioner", "display": "Smith K", "reference": "#contributor35"}, "forenameInitials": "K"}, {"affiliation": [{"display": "Statistical Centre for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA."}], "contributor": {"type": "Practitioner", "display": "Hanscom B", "reference": "#contributor36"}, "forenameInitials": "B"}, {"affiliation": [{"display": "University of North Carolina (UNC) at Chapel Hill, Chapel Hill, NC, USA."}], "contributor": {"type": "Practitioner", "display": "Cohen MS", "reference": "#contributor37"}, "forenameInitials": "MS"}, {"affiliation": [{"display": "University of North Carolina (UNC) at Chapel Hill, Chapel Hill, NC, USA; UNC Project-Malawi, Lilongwe, Malawi."}], "contributor": {"type": "Practitioner", "display": "Hosseinipour MC", "reference": "#contributor38"}, "forenameInitials": "MC"}, {"contributor": {"type": "Organization", "display": "HPTN 084 study group", "reference": "#contributor39"}}], "complete": true}, "publicationForm": [{"issue": "10337", "volume": "399", "language": [{"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}], "pageString": "1779-1789", "articleDate": "2022-05-07", "citedMedium": {"coding": [{"code": "internet", "system": "http://terminology.hl7.org/CodeSystem/cited-medium", "display": "Internet"}]}, "publishedIn": {"type": {"coding": [{"code": "D020492", "system": "http://terminology.hl7.org/CodeSystem/published-in-type", "display": "Periodical"}]}, "title": "Lancet (London, England)", "identifier": [{"type": {"text": "Electronic ISSN Type", "coding": [{"code": "Electronic", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn", "display": "Electronic"}]}, "value": "1474-547X", "system": "https://portal.issn.org"}, {"type": {"text": "ISOAbbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "Lancet", "system": "https://www.issn.org/services/online-services/access-to-the-ltwa/"}, {"type": {"text": "ISSN Linking", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "0140-6736", "system": "https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/"}, {"type": {"text": "Medline Title Abbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "Lancet", "system": "https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html"}, {"type": {"text": "NLM Unique ID", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "2985213R", "system": "https://locatorplus.gov/cgi-bin/Pwebrecon.cgi?DB=local"}], "publisherLocation": "England"}}, {"articleDate": "2022-04-01", "citedMedium": {"coding": [{"code": "internet-without-issue", "system": "http://terminology.hl7.org/CodeSystem/cited-medium", "display": "Internet without issue"}]}}], "relatedIdentifier": [{"value": "NCT03164564", "system": "https://clinicaltrials.gov", "assigner": {"display": "NLM"}}]}, "classification": [{"type": {"coding": [{"code": "citation-source", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "Citation Source"}]}, "classifier": [{"text": "MEDLINE"}]}, {"type": {"coding": [{"code": "medline-owner", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "MEDLINE Citation Owner"}]}, "classifier": [{"coding": [{"code": "NLM", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value", "display": "National Library of Medicine, Index Section", "userSelected": false}]}]}], "lastReviewDate": "2023-03-17", "description": "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."}